Moleculin Reports First Quarter 2023 Financial Results

Go back to Moleculin Reports First Quarter 2023 Financial Results
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.77 --0 (-0%)
Previous Close $0.77    52 Week High $9.58 
Open $0.77    52 Week Low $2.34 
Day High $0.77    P/E N/A 
Day Low $0.77    EPS $-0.34 
Volume 24,367